+1 628 258 0071(US) +44
2035 002 764(UK)
Search For Reports
GET FREE SAMPLE R
Home / Reports
/ Breast Biopsy Market
The global breast biopsy market is expected to grow significantly during the forecast period (2018–2023).
A biopsy is a small operation performed to remove tissues from an area of concern in the body. Breast biopsy
is a procedure that involves testing of small samples of breast tissues for detecting breast cancer. Breast
biopsies are conducted using minimal invasive biopsy systems, owing to minimal disfigurement and pain.
There are different types of biopsy procedures depending on the technique, such as core needle biopsy (CNB),
fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB) recommended by the doctor based on
the location, size, and other characteristics of the breast abnormality.
The increase in the prevalence of breast cancer, especially among women above the age of 35 during
menopause (are more susceptible to breast cancer) and growth in the awareness regarding breast cancer
screening programs drive the market growth. However, unspecified regulatory issues, infection risks
connected with breast biopsy procedures, and ambiguous reimbursement policies are the factors limiting the
market growth. Additionally, restraints for the market include the high cost of surgical procedures and risks
involved in them. Conversely, the emergence of technologically-advanced and minimally invasive breast
biopsy devices are expected to provide lucrative opportunities in the untapped market.
The global breast biopsy market has been segmented on the basis of product, technique type, guidance
technology, and end-user.
On the basis of product, the market has been classified as biopsy needles, biopsy tables, biopsy wires,
guidance systems, and others.
On the basis of technique type, the market is classified into fine needle aspiration biopsy, core needle biopsy,
biopsy markers, MR